In prostate cancer cells, SUCLG2 enhances the succinic synthetase activity of mitochondrial nucleoside diphosphokinase and promotes leukemia suppressor receptor signaling to enhance prostate cancer aggressiveness [17]. The gene discussed is SUCLG2; the disease is prostate cancer.